Portfolio (Quarterly)
Guide ↗
Boxer Capital Management, LLC
· CIK 0002018299| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 9,771,485.0 | $82.1M | 26.16% | — | — | $8.40 | +196.7% |
| 2 | QURE | UNIQURE NV | Healthcare | 800,000.0 | $46.7M | 14.88% | -100K | -11.1% | $58.37 | -34.5% |
| 3 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 400,000.0 | $18.7M | 5.95% | -393K | -49.6% | $46.70 | +338.9% |
| 4 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 319,100.0 | $18.1M | 5.76% | -113K | -26.1% | $56.60 | +97.8% |
| 5 | KOD | KODIAK SCIENCES INC | Healthcare | 750,000.0 | $12.3M | 3.91% | — | — | $16.37 | +97.6% |
| 6 | PTCT | PTC THERAPEUTICS INC | Healthcare | 200,000.0 | $12.3M | 3.91% | NEW | — | $61.37 | +2.1% |
| 7 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 900,000.0 | $12.2M | 3.90% | -325K | -26.5% | $13.59 | +117.0% |
| 8 | URGN | UROGEN PHARMA LTD | Healthcare | 575,000.0 | $11.5M | 3.66% | — | — | $19.95 | +107.3% |
| 9 | — | MERUS N V | — | 120,000.0 | $11.3M | 3.60% | -245K | -67.1% | $94.15 | — |
| 10 | CYTK | CYTOKINETICS INC | Healthcare | 200,000.0 | $11.0M | 3.50% | NEW | — | $54.96 | +17.6% |
| 11 | ABVX | ABIVAX SA | Healthcare | 120,000.0 | $10.2M | 3.25% | NEW | — | $84.90 | +7.3% |
| 12 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 110,000.0 | $7.3M | 2.33% | +50K | +83.3% | $66.43 | +113.5% |
| 13 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 125,000.0 | $7.1M | 2.27% | — | — | $56.90 | +0.3% |
| 14 | — | CRESCENT BIOPHARMA INC. | — | 453,686.0 | $5.4M | 1.72% | — | — | $11.89 | — |
| 15 | — | INOVIO PHARMACEUTICALS INC | — | 2,300,000.0 | $5.4M | 1.72% | NEW | — | $2.34 | — |
| 16 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 250,000.0 | $4.8M | 1.54% | +225K | +900.0% | $19.27 | -3.1% |
| 17 | — | CIDARA THERAPEUTICS INC | — | 48,000.0 | $4.6M | 1.47% | -7K | -12.7% | $95.76 | — |
| 18 | CELC | CELCUITY INC | Healthcare | 90,000.0 | $4.4M | 1.42% | NEW | — | $49.40 | +61.0% |
| 19 | REPL | REPLIMUNE GROUP INC | Healthcare | 1,050,000.0 | $4.4M | 1.40% | -1.2M | -52.5% | $4.19 | +195.0% |
| 20 | — | SOLID BIOSCIENCES INC | — | 600,000.0 | $3.7M | 1.18% | NEW | — | $6.17 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%